CHIPTS at AIDS 2024

The 25th International AIDS Conference (AIDS 2024), will take place in Munich, Germany, from July 22-26, 2024. Pre-conferences will be held on July 20-22, 2024. Learn more about AIDS 2024 and the exciting work of our CHIPTS scientists featured at the conference below.

What is AIDS 2024?

The International AIDS Conference is the world’s largest conference on HIV and AIDS. As a global platform to advance the HIV response, it sits uniquely at the intersection of science, advocacy, and human rights. The 25^th International AIDS Conference, AIDS 2024, will convene thousands of people living with, affected by, and working on HIV to share knowledge, best practices, and lessons learned from the HIV response over the past 40 years.

The theme for AIDS 2024, “Put people first,” reflects the organizers’ acknowledgment of the HIV pandemic as a significant threat to public health and individual well-being. This principle of prioritizing people is essential in guiding efforts aimed at ending the HIV pandemic.

Several CHIPTS scientists will be sharing exciting research findings and project updates at AIDS 2024, contributing to the dissemination of crucial information that advances HIV prevention and treatment initiatives globally. We are delighted to highlight satellite sessions, oral session abstracts, and poster session abstracts featuring the important work of our CHIPTS scientists.

Monday, July 22, 2024

Satellite Session

SAT015 – HIV-related intersectional stigma reduction and discrimination intervention findings from NIH Promoting Reductions in Intersectional StigMa (PRISM) clinical trials

Session Start: 9:30 AM (Room 5/Channel 8)
Presentation Title: A CBT-group intervention to increase HIV testing and PrEP use among Latino sexual minority men (R01MH121256; NCT04225832) (Laura Bogart)

Tuesday, July 23, 2024

Oral Abstract Session

OAE04 – Advanced HIV disease: Hiding in plain sight

Session Start: 3:00 PM (Room 14b/Channel 3)
Presentation Title: Performance characteristics of HIV RNA screening with long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) in the multicenter global HIV Prevention Trials Network 083 (HPTN 083) Study (Raphael Landovitz)

Poster Session

Poster Abstract – TUPEC186

Session Start: 12:00 PM
Poster Title: Technology-based Interventions, with a stepped care approach, for reducing sexual risk behaviors and increasing PrEP initiation among Transgender and Gender Expansive Youth and Young Adults (ATN 160)
Authors: K.J. Horvath, D. Cain, J.A. Rusow, D. Benkeser, L. Schader, B.A. Gwiazdowski, S.J. Skeen, M. Hannah, M. Belzer, M. Castillo, K.H. Mayer, M.E. Paul, J. Hill-Rorie, N. Dorcey-Johnson, J. McAvoy-Banerjea, T. Sanchez, P.S. Sullivan, L. Hightow-Weidman, C.J. Reback

Wednesday, July 24, 2024

Satellite Session

SAT074 – Latching onto freedom: A global dialogue on reproductive justice for women living with HIV

Session Start: 7:00 AM (Room 14a/Channel 9)
Presentation Title: Dignified breastfeeding for women living with HIV through the U=U framework (Dvora Davey)

Poster Sessions

Poster Abstract – WEPEB101

Session Start: 12:00 PM
Poster Title: Prediction of intracellular tenofovir-diphosphate concentrations during pregnancy using a semi-mechanism-based population pharmacokinetic model
Authors: Yu, R. Bies, J. Momper, B. Best, M. Mirochnick, R. Heffron, C. Celum, K. Brooks, P. Anderson, M. Marzinke, D. Joseph Davey, L. Myer, G. Doncel, C. Hendrix, R. Scott

Poster Abstract – WEPEC206

Session Start: 12:00 PM
Poster Title: “Everyone should have access to it”: perspectives on PrEP product choice and implementation from MSM and TGW in an injectable PrEP trial
Authors: Psaros, R.J. Landovitz, E.M. Waldron, W. Rice, C.F. Kelley, T. Oyedele, L. Coehlo, N. Phanuphak, Y. Singh, K. Middelkoop, S. Griffith, M. McCauley, A.M. Rivas, O.Y. Chen, T. Jupimai, N. Lawrence, G. Goodman, J. Rooney, A. Rinehart, J. Clark, V. Go, J. Sugarman, S. Fields, A. Adeyeye, B. Grinsztejn, S.A. Safren

Poster Abstract – WEPEE545

Session Start: 12:00 PM
Poster Title: Telemedicine to improve health equity in two federally qualified health centers in Los Angeles: is telephone the answer?
Authors: Walker, C. Moucheraud, D. Butler, J. de Vente, K. Tangonan, C. Takayama, T. Horn, S. Shoptaw, J.S. Currier, J. Gladstein, R. Hoffman

Poster Abstract – WEPEC307

Session Start: 12:00 PM
Poster Title: Effect of high-risk mobility on treatment interruption among men in Malawi: secondary analysis of two randomized controlled trials
Authors: Thorp, K. Balakasi, M. Ramesh, I. Robson, A. Choko, R. Hoffman, S. Shoptaw, K. Dovel

Poster Abstract – WEPEC302

Session Start: 12:00 PM
Poster Title: Acceptability of long-acting injectable antiretroviral treatment (LAI-ART) among young Black sexual minority men (SMM) living with HIV in the Southern United States
Authors: Ogunbajo, W. Vincent, D. Siconolfi, C. Campbell, L. Pollack, S. Kegeles, G. Rebchook, S. Tebbetts, E. Storholm

Poster Abstract – WEPED343

Session Start: 12:00 PM
Poster Title: Implementation of a hybrid online-offline intervention to address HIV stigma and gender disparity for women living with HIV in Vietnam
Authors: C. Lin, B.D. Nguyen, H. Dang, T.T. Nguyen, L. Li, M.G. Le

Thursday, July 25, 2024

Poster Sessions

Poster Abstract – THPEE516

Session Start: 12:00 PM
Poster Title: FastPrEP: evaluating factors associated with PrEP initiation from community-based mobile clinics compared to fixed-site primary health facilities in adolescents and young people in Cape Town, South Africa
Authors: Rousseau, K. Lebelo, N. Mathola, P. Macdonald, O. Vanto, P. Fuzile, P. Smith, T. Wonxie, L. Fynn, M. Wallace, D. Davey, L.-G. Bekker

Poster Abstract – THPEC176

Session Start: 12:00 PM
Poster Title: Impact of changing PrEP regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023)
Authors: Q.L. Pham, N. Setrakian, H.T. Bui, P. Adamson, T.N. Hoang, L.M. Giang, P.M. Gorbach

Poster Abstract – THPEA029

Session Start: 12:00 PM
Poster Title: A first-in-human phase 1 trial of PGT121.414.LS administered alone and in combination with VRC07-523LS: safety, tolerability, pharmacokinetics, and neutralization activity (HVTN 136/HPTN 092)
Authors: Edupuganti, C. Hurt, K. Stephenson, Y. Huang, C. Paez, C. Yu, C. Yen, B. Hanscom, Z. He, M. Miner, T. Gamble, J. Heptinstall, K.E. Seaton, A. Eaton, S. Regenold, W. Chege, M. Anderson, N. McCloskey, L. Zhang, E. Piwowar-Manning, M.E. Ackerman, M. Pensiero, B. Dye, R.J. Landovitz, K.H. Mayer, M. Siegel, M. Sobieszczyk, S.R. Walsh, L. Gama, D.H. Barouch, D. Montefiori, G. Tomaras, HVTN136/HPTN 092 study team

Poster Abstract – THPEC292

Session Start: 12:00 PM
Poster Title: Increasing COVID-19 vaccine coverage among art clients through a comprehensive vaccination intervention in Kasungu district, Malawi
Authors: Chivwara, C. Saini, R. Khunga, E. Makwakwa, H. Kanise, J. Njala, D. Smith, S. Phiri, C. Moucheraud, E. Chikuse, R. Hoffman, J. van Oosterhout

Poster Abstract – THPED380

Session Start: 12:00 PM
Poster Title: HPTN 094: engaging key community stakeholders in preparation for mobile clinics providing integrated health services (medication for opioid use disorder and HIV treatment/prevention services) for people who inject drugs (PWID)
Authors: Albano, J. Harris, C. Blades, A. Davis, J. Lucas, S. Alvarado, J. Yeager, S. Edwards, P. Andrew, N. El-Bassel, S. Shoptaw

Poster Abstract – THPED326

Session Start: 12:00 PM
Poster Title: Health or income? How men living with HIV in Malawi experience and navigate decisions between income generation and ART refills
Authors: Ramesh, K. Balakasi, J. Hubbard, M. Thorp, L. Kamtsendero, M. Sanena, S. Phiri, M. Cornell, T. Coates, K. Holland, A. Choko, K. Dovel

Poster Abstract – THPEC277

Session Start: 12:00 PM
Poster Title: Factors associated with repeat treatment interruption among men in Malawi: findings from two randomized control trials
Authors: K.T. Balakasi, M. Thorp, I. Robson, M. Mphande, C. Lemani, A. Choko, S. Phiri, R. Hoffman, T.J. Coates, K. Dovel

Poster Abstract – LB18

Session Start: 12:00 PM
Poster Title: Efficacy and safety of ensitrelvir in non-hospitalized adults at standard or high risk of progression to severe COVID-19: the SCORPIO-HR phase 3, randomized, double-blind, placebo-controlled trial
Authors: K. Chew, A. Luetkemeyer, S. Lacey, M. Hughes, L. Harrison, E. Daar, J. Eron, C. Fletcher, A. Greninger, D. Hessinger, J. Li, D. Mailhot, D. Wohl, M. Chayakulkeeree, P. Elistratova, O. Makinde, G. Morgan, S. Portsmouth, T. Uehara, D. Smith, J. Currier, on behalf of the SCORPIO-HR/ACTIV-2d (ACTG A5407) study team

Poster Abstract – LB32

Session Start: 12:00 PM
Poster Title: Understand how health, well-being, social support, violence, and stigma shape resilience pathways among Kenyan youth aged 15-24 living with HIV in urban informal settlements through structural equation modeling
Authors: Wang, H. Owoko, C. Kabiru, P. Gorbach, S. Muyingo

Friday, July 26, 2024

Oral Abstract Session

OAD37 – Exploring the kaleidoscope of experiences among people living with HIV

Session Start: 12:00 PM (Room 5/Channel 8)
Presentation Title: Primary outcomes of an intervention employing a hybrid online-offline approach to address HIV stigma among women living with HIV in Vietnam (Chunqing Lin)

Poster Sessions

E-Poster Abstract – EPB026

Session Start: 12:00 PM
Poster Title: Association of antiretroviral therapy with cognition and resting-state functional connectivity in people with HIV
Authors: Ibnidris, J. Ipser, T. M. Nir, L. Chang, R. A. Cohen, T. Ernst, K. J. Kallianpur, E. C. Porges, C. M. Shikuma, S. Thomopoulos, H. J. Zar, P. M. Thompson, S. Shoptaw, D. J. Stein, N. Jahanshad, ENIGMA HIV Working Group

E-Poster Abstract – EPE158

Session Start: 12:00 PM
Poster Title: Assessing preferences of long-acting PrEP modalities among oral PrEP-experienced postpartum individuals in Cape Town, South Africa: a qualitative study
Authors: Wara, L. Court, K. Moopelo, N. Mashele, C. Ntwasa, R. Mvududu, A. Miller, S. Schoetz Dean, C. Orrell, L. Knight, L. Myer, R. Hoffman, D. Joseph Davey

To learn more about AIDS 2024 and access the conference materials, visit: https://www.iasociety.org/conferences/aids2024